BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2015
View Archived Issues
Adapt Pharma successfully completes pharmacokinetic study of intranasal naloxone
Read More
VolitionRx and Hvidovre Hospital initiate trial to identify NuQ biomarkers for colorectal polyps
Read More
Biohaven advancing BHV-0223 toward phase I trial
Read More
Enrollment open in phase II study of GI-6301 for chordoma
Read More
European CANCER-ID consortium formed to validate blood biomarkers of cancer
Read More
Shanghai De Novo Pharmatech characterizes AML candidate SC-110237
Read More
Clinical data reported for antibody-drug conjugate SGN-CD33A
Read More
ThromboGenics starts developing Jetrea for retinal vein occlusion
Read More
Janssen seeks Japanese approval of Risperdal for irritability in children with autistic disorder
Read More
Karus Therapeutics presents PI3Kbeta/delta inhibitors
Read More
U.S. orphan drug designation awarded to Dicerna's DCR-PH1 for primary hyperoxaluria type 1
Read More
Celgene and MedImmune collaborate to develop MEDI-4736 for hematologic malignancies
Read More
Bayer patents FXIa inhibitors
Read More
Bayer seeks Japanese approval for radium-223 dichloride
Read More
Janssen Pharmaceutica discloses NIK inhibitors
Read More
Cortendo reports development of novel cytochrome P450 inhibitors
Read More
Korean researchers present HRP-3 inhibitors
Read More
Roche divulges new tau-imaging compounds
Read More
FDA approves label update to Pomalyst
Read More
Aerie reports results from first registrational study of Rhopressa
Read More
FDA grants priority review to idarucizumab BLA
Read More
World Malaria Day: unveiling parasite resistance mechanisms
Read More
Actavis launches Avycaz in U.S.
Read More
AstraZeneca and Innate Pharma collaborate on development of IPH-2201
Read More